Found: 10
Select item for more details and to access through your institution.
Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 729, doi. 10.1007/s10637-010-9561-9
- By:
- Publication type:
- Article
Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 109, n. 1, p. 137, doi. 10.1007/s11060-012-0879-3
- By:
- Publication type:
- Article
Salvage surgical resection after high‐dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): A potential positive selection bias—A study of the Spanish Group for Research on Sarcomas (GEIS)Presented in part at the Thirty‐Eighth Annual Meeting of the American Society of Clinical Oncology, Orlando, May 18–21, 2002.
- Published in:
- Journal of Surgical Oncology, 2004, v. 88, n. 1, p. 44, doi. 10.1002/jso.20131
- By:
- Publication type:
- Article
Neuropatía inducida por el tratamiento médico del cáncer.
- Published in:
- Médicas UIS, 2010, v. 23, n. 2, p. 100
- By:
- Publication type:
- Article
Mitomycin-C and Vinblastine in Advanced Breast Cancer.
- Published in:
- Oncology, 1989, v. 46, n. 3, p. 137, doi. 10.1159/000226702
- By:
- Publication type:
- Article
Phase II trial of dacomitinib, a pan‒human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1522, doi. 10.1093/neuonc/nox105
- By:
- Publication type:
- Article
Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 9, p. 677, doi. 10.1007/s12094-011-0714-x
- By:
- Publication type:
- Article
Update on the diagnosis of cancer of unknown primary (CUP) origin.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 7, p. 434, doi. 10.1007/s12094-011-0679-9
- By:
- Publication type:
- Article
Approval denied by the European Medicines Agency (EMA) for bevacizumab in the treatment of high-grade glioma recurrence: a good idea or a grave error?
- Published in:
- 2011
- By:
- Publication type:
- Letter
Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 7, p. 1498
- By:
- Publication type:
- Article